ARTICLE | Company News
GlobeImmune cancer news
September 21, 2015 7:00 AM UTC
In August, GlobeImmune hired Cantor Fitzgerald & Co. to evaluate strategic options, including a merger or sale of all or part of the company. Earlier this year, Celgene Corp. (NASDAQ:CELG, Summit, N....